肌层浸润性膀胱癌-话题@MedSci

#肌层浸润性膀胱癌#

36篇内容 | 2189人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1662652, encodeId=1bb4166265236, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=BJU Int：新辅助化疗在肌层浸润性膀胱癌和恶性输尿管梗阻患者中的安全性研究, objectType=article, longId=210132, objectId=bfb821013282, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfb821013282, replyNumber=0, likeNumber=147, createdTime=2021-10-16, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfb821013282, moduleTitle=BJU Int：新辅助化疗在肌层浸润性膀胱癌和恶性输尿管梗阻患者中的安全性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfb821013282)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662656, encodeId=42861662656c6, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=Eur Urol Focus：影像组学在预测肌层浸润性膀胱癌中的作用 , objectType=article, longId=213082, objectId=e7452130823c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7452130823c, replyNumber=0, likeNumber=96, createdTime=2021-06-27, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7452130823c, moduleTitle=Eur Urol Focus：影像组学在预测肌层浸润性膀胱癌中的作用 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7452130823c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662649, encodeId=5de41662649f1, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=Eur Urol：肌层浸润性膀胱癌患者接受新辅助化疗后的（化疗）放疗结果 , objectType=article, longId=204691, objectId=0df8204691cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0df8204691cc, replyNumber=0, likeNumber=79, createdTime=2021-09-10, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0df8204691cc, moduleTitle=Eur Urol：肌层浸润性膀胱癌患者接受新辅助化疗后的（化疗）放疗结果 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0df8204691cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662653, encodeId=e584166265381, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=Eur Urol Focus：NF Kappa B受体激活剂（RANK）的表达与肌层浸润性膀胱癌患者预后的关系, objectType=article, longId=212061, objectId=c38421206136, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c38421206136, replyNumber=0, likeNumber=68, createdTime=2021-11-07, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c38421206136, moduleTitle=Eur Urol Focus：NF Kappa B受体激活剂（RANK）的表达与肌层浸润性膀胱癌患者预后的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c38421206136)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662654, encodeId=ec87166265410, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=Eur Urol Oncol：非肌层浸润性膀胱癌患者的长期随访及与主动监测失败相关的因素 , objectType=article, longId=212985, objectId=800a21298528, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=800a21298528, replyNumber=0, likeNumber=62, createdTime=2021-07-09, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=800a21298528, moduleTitle=Eur Urol Oncol：非肌层浸润性膀胱癌患者的长期随访及与主动监测失败相关的因素 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=800a21298528)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662651, encodeId=2ac21662651e0, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=临床阶段生物制药公司宣布开展卡妥索双抗治疗非肌层浸润性膀胱癌临床I/II期试验, objectType=article, longId=209970, objectId=4f092099e063, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f092099e063, replyNumber=0, likeNumber=64, createdTime=2021-11-09, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f092099e063, moduleTitle=临床阶段生物制药公司宣布开展卡妥索双抗治疗非肌层浸润性膀胱癌临床I/II期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f092099e063)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662648, encodeId=2b8c166264884, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=Eur Urol：经尿道膀胱肿瘤切除术治疗非肌层浸润性膀胱癌质量和效果的改善 , objectType=article, longId=199015, objectId=4bd4199015cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bd4199015cc, replyNumber=0, likeNumber=69, createdTime=2020-12-26, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bd4199015cc, moduleTitle=Eur Urol：经尿道膀胱肿瘤切除术治疗非肌层浸润性膀胱癌质量和效果的改善 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bd4199015cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662647, encodeId=0110166264e68, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=Eur Urol：分子亚型和免疫浸润对肌层浸润性膀胱癌新辅助Pembrolizumab治疗的病理响应和结果影响, objectType=article, longId=190995, objectId=3a86190995c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a86190995c8, replyNumber=0, likeNumber=42, createdTime=2020-10-02, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a86190995c8, moduleTitle=Eur Urol：分子亚型和免疫浸润对肌层浸润性膀胱癌新辅助Pembrolizumab治疗的病理响应和结果影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a86190995c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662643, encodeId=e38b1662643dd, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=非肌层浸润性膀胱癌膀胱灌注治疗专家共识, objectType=article, longId=164781, objectId=0d28164e813d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d28164e813d, replyNumber=0, likeNumber=65, createdTime=2020-02-20, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d28164e813d, moduleTitle=非肌层浸润性膀胱癌膀胱灌注治疗专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d28164e813d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662646, encodeId=3cc41662646eb, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=中国非肌层浸润性膀胱癌治疗与监测循证临床实践指南（2018年标准版）, objectType=article, longId=177597, objectId=fff21e759775, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fff21e759775, replyNumber=0, likeNumber=65, createdTime=2019-09-13, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fff21e759775, moduleTitle=中国非肌层浸润性膀胱癌治疗与监测循证临床实践指南（2018年标准版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fff21e759775)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662645, encodeId=bc841662645cb, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=肌层浸润性膀胱癌的根治性切除与保留膀胱综合治疗, objectType=article, longId=175262, objectId=9eea1e52621c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9eea1e52621c, replyNumber=0, likeNumber=79, createdTime=2019-12-20, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9eea1e52621c, moduleTitle=肌层浸润性膀胱癌的根治性切除与保留膀胱综合治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9eea1e52621c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662642, encodeId=09ae1662642d9, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=2019 CUA指南：肌层浸润性膀胱癌, objectType=article, longId=161039, objectId=1eeb161039df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1eeb161039df, replyNumber=0, likeNumber=65, createdTime=2019-08-20, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1eeb161039df, moduleTitle=2019 CUA指南：肌层浸润性膀胱癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1eeb161039df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662644, encodeId=4c2b1662644f4, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=肌层浸润性膀胱癌的治疗：TAR-200在Ib期试验中的阳性结果, objectType=article, longId=174335, objectId=93c21e43356e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93c21e43356e, replyNumber=0, likeNumber=76, createdTime=2020-05-29, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93c21e43356e, moduleTitle=肌层浸润性膀胱癌的治疗：TAR-200在Ib期试验中的阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93c21e43356e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662641, encodeId=19f41662641d9, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=中国非肌层浸润性膀胱癌治疗与监测循证临床实践指南（2018简化版）, objectType=article, longId=158342, objectId=d3a9158342b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3a9158342b3, replyNumber=0, likeNumber=42, createdTime=2019-10-05, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3a9158342b3, moduleTitle=中国非肌层浸润性膀胱癌治疗与监测循证临床实践指南（2018简化版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3a9158342b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662639, encodeId=3fe41662639db, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=【2018 ESMO】KEYNOTE-057研究：卡介苗治疗无效的高风险非肌层浸润性膀胱癌，帕博利珠单抗显疗效, objectType=article, longId=152388, objectId=65e815238817, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65e815238817, replyNumber=0, likeNumber=69, createdTime=2018-11-03, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65e815238817, moduleTitle=【2018 ESMO】KEYNOTE-057研究：卡介苗治疗无效的高风险非肌层浸润性膀胱癌，帕博利珠单抗显疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65e815238817)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662638, encodeId=535b1662638be, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=2018 ICBN共识：肌层浸润性膀胱癌的随访建议, objectType=article, longId=131902, objectId=998f1319025f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=998f1319025f, replyNumber=0, likeNumber=62, createdTime=2018-05-09, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=998f1319025f, moduleTitle=2018 ICBN共识：肌层浸润性膀胱癌的随访建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=998f1319025f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662640, encodeId=9050166264008, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=JCO：Pembrolizumab新辅助治疗肌层浸润性膀胱癌, objectType=article, longId=152424, objectId=e34715242443, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e34715242443, replyNumber=0, likeNumber=0, createdTime=2019-06-06, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e34715242443, moduleTitle=JCO：Pembrolizumab新辅助治疗肌层浸润性膀胱癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e34715242443)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662636, encodeId=dcb3166263687, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=2017 EAU指南：非肌层浸润性膀胱癌（Ta, T1, CIS）, objectType=article, longId=112057, objectId=295711205e80, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=295711205e80, replyNumber=0, likeNumber=38, createdTime=2018-01-21, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=295711205e80, moduleTitle=2017 EAU指南：非肌层浸润性膀胱癌（Ta, T1, CIS）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=295711205e80)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662637, encodeId=8f32166263e6a, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=非肌层浸润性膀胱癌二次电切中国专家共识, objectType=article, longId=113958, objectId=4cc3113958dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cc3113958dc, replyNumber=0, likeNumber=66, createdTime=2017-10-06, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cc3113958dc, moduleTitle=非肌层浸润性膀胱癌二次电切中国专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cc3113958dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662635, encodeId=13f616626350e, content=<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>, objectTitle=Eur Urol：丝裂霉素C即刻膀胱灌注治疗非肌层浸润性膀胱癌的价值。, objectType=article, longId=107253, objectId=06d510e25387, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06d510e25387, replyNumber=0, likeNumber=78, createdTime=2017-09-24, rootId=0, userName=12498768m21(暂无昵称), userId=3dd925444855, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06d510e25387, moduleTitle=Eur Urol：丝裂霉素C即刻膀胱灌注治疗非肌层浸润性膀胱癌的价值。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06d510e25387)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肌层浸润性膀胱癌

2020-05-29

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

BJU Int：新辅助化疗在肌层浸润性膀胱癌和恶性输尿管梗阻患者中的安全性研究

2021-10-16

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

Eur Urol Focus：影像组学在预测肌层浸润性膀胱癌中的作用

2021-06-27

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

Eur Urol：肌层浸润性膀胱癌患者接受新辅助化疗后的（化疗）放疗结果

2021-09-10

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

Eur Urol Focus：NF Kappa B受体激活剂（RANK）的表达与肌层浸润性膀胱癌患者预后的关系

2021-11-07

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

Eur Urol Oncol：非肌层浸润性膀胱癌患者的长期随访及与主动监测失败相关的因素

2021-07-09

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

临床阶段生物制药公司宣布开展卡妥索双抗治疗非肌层浸润性膀胱癌临床I/II期试验

2021-11-09

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

Eur Urol：经尿道膀胱肿瘤切除术治疗非肌层浸润性膀胱癌质量和效果的改善

2020-12-26

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

Eur Urol：分子亚型和免疫浸润对肌层浸润性膀胱癌新辅助Pembrolizumab治疗的病理响应和结果影响

2020-10-02

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

非肌层浸润性膀胱癌膀胱灌注治疗专家共识

2020-02-20

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

中国非肌层浸润性膀胱癌治疗与监测循证临床实践指南（2018年标准版）

2019-09-13

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

肌层浸润性膀胱癌的根治性切除与保留膀胱综合治疗

2019-12-20

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

2019 CUA指南：肌层浸润性膀胱癌

2019-08-20

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

肌层浸润性膀胱癌的治疗：TAR-200在Ib期试验中的阳性结果

2020-05-29

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

中国非肌层浸润性膀胱癌治疗与监测循证临床实践指南（2018简化版）

2019-10-05

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

【2018 ESMO】KEYNOTE-057研究：卡介苗治疗无效的高风险非肌层浸润性膀胱癌，帕博利珠单抗显疗效

2018-11-03

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

2018 ICBN共识：肌层浸润性膀胱癌的随访建议

2018-05-09

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

JCO：Pembrolizumab新辅助治疗肌层浸润性膀胱癌

2019-06-06

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

2017 EAU指南：非肌层浸润性膀胱癌（Ta, T1, CIS）

2018-01-21

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

非肌层浸润性膀胱癌二次电切中国专家共识

2017-10-06

12498768m21(暂无昵称) (审核中...)

前往app查看评论内容

#肌层浸润性膀胱癌#

Eur Urol：丝裂霉素C即刻膀胱灌注治疗非肌层浸润性膀胱癌的价值。

2017-09-24

科室
- - 订阅+
  - 更多科室
工具
服务